Health - Latest News Search Engine - Global and Local Breaking News

Health

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

Definitive agreement to result in one-time $225 million cash payment Theravance Biopharma retains rights to up to $150 million in milestones from Roya...

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

Maxwell Healthcare Associates Announces Rebrand to Maxwell TEC

SHOREVIEW, Minn., June 2, 2025 /PRNewswire/ -- Maxwell Healthcare Associates (MHA) announced today its rebrand to Maxwell TEC, signaling a renewed foc...

Maxwell Healthcare Associates Announces Rebrand to Maxwell TEC

BioArctic's Capital Markets Day 2025 - entering a new era of growth

STOCKHOLM, June 2, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the c...

BioArctic's Capital Markets Day 2025 - entering a new era of growth

iOnctura bolsters leadership team with new appointments

Steven Sciuto joins as Chief Financial Officer (CFO) bringing a wealth of experience in scaling finance functions as well as in private and public fin...

iOnctura bolsters leadership team with new appointments

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic ...

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable T...

Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter

Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national ...

Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

Firma Medicilon úspěšně prošla inspekcí Úřadu pro kontrolu potravin a léčiv, což potvrzuje její pozici globální špičky v oblasti výzkumu a vývoje

BOSTON, 2. června 2025 /PRNewswire/ -- Společnost Medicilon Preclinical Research (Shanghai) LLC (dále také jen „Medicilon") oznámila, že 20. května ús...

Firma Medicilon úspěšně prošla inspekcí Úřadu pro kontrolu potravin a léčiv, což potvrzuje její pozici globální špičky v oblasti výzkumu a vývoje

BIAL Announces Oral Presentation at GBA1 Meeting 2025

PORTO, Portugal, June 2, 2025 /PRNewswire/ -- BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today a...

BIAL Announces Oral Presentation at GBA1 Meeting 2025

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained

SLOUGH, England and RICHMOND, Va., June 2, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its intention to cancel: (i) the secon...

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained

Medicilon успешно прошла проверку FDA, укрепив глобальное признание своих достижений в области исследований и разработок

БОСТОН, 2 июня 2025 г. /PRNewswire/ -- 20 мая компания Medicilon Preclinical Research (Shanghai) LLC («Medicilon») объявила о завершении проведения FD...

Medicilon успешно прошла проверку FDA, укрепив глобальное признание своих достижений в области исследований и разработок

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio PARIS and CAMBRIDGE, Mass., June ...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025

Significant anti-tumor responses and reduction of brain metastases observed SEOUL, South Korea , June 1, 2025 /PRNewswire/ -- J INTS BIO, a company sp...

J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-c...

Pharmacists warn drug shortage affecting cancer patients

Some patients are skipping meals due to a shortage of Creon, says a pharmacy association.

Pharmacists warn drug shortage affecting cancer patients

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) f...

SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical co...

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with ...

Conference call and webcast to be held at 8:30 a.m. ET NEW HAVEN, Conn., June 1, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clini...

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

SIBIONICS Hosts the 3rd AGP&DTx Summit Forum: Breakthroughs Ahead

SHENZHEN, China, June 1, 2025 /PRNewswire/ -- On May 31, SIBIONICS Successfully Hosts the 3rd AGP & DTx Summit Forum in Shenzhen, China, bringing ...

SIBIONICS Hosts the 3rd AGP&DTx Summit Forum: Breakthroughs Ahead

The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program

GAINESVILLE, Fla., June 1, 2025 /PRNewswire/ -- The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a gr...

The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

Oncologist Dr. Asma Dilawari and palliative care physician Dr. Nelia Jain join to expand survivorship program and scale supportive care and palliative...

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population